[go: up one dir, main page]

ES2168334T3 - Composicion para el tratamiento de la piel. - Google Patents

Composicion para el tratamiento de la piel.

Info

Publication number
ES2168334T3
ES2168334T3 ES95302500T ES95302500T ES2168334T3 ES 2168334 T3 ES2168334 T3 ES 2168334T3 ES 95302500 T ES95302500 T ES 95302500T ES 95302500 T ES95302500 T ES 95302500T ES 2168334 T3 ES2168334 T3 ES 2168334T3
Authority
ES
Spain
Prior art keywords
composition
skin treatment
skin
contain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95302500T
Other languages
English (en)
Inventor
Kelly Hua Zhang
Richard Kosturko
John Bartolone
Anthony Vincent Rawlings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2168334T3 publication Critical patent/ES2168334T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE TRATA DE COMPOSICIONES PARA EL TRATAMIENTO DE LA PIEL QUE CONTIENEN UN SISTEMA PARA INTENSIFICAR LA PRODUCCION DE ESFINGOLIPIDOS EN LA PIEL QUE CONTIENEN N-ACETIL-L-CISTEINA Y UN ACIDO ALFA HIDROXI (O UNA SAL, O UN ESTER DEL MISMO).
ES95302500T 1994-04-25 1995-04-13 Composicion para el tratamiento de la piel. Expired - Lifetime ES2168334T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/232,896 US5451405A (en) 1994-04-25 1994-04-25 Skin treatment composition

Publications (1)

Publication Number Publication Date
ES2168334T3 true ES2168334T3 (es) 2002-06-16

Family

ID=22875036

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95302500T Expired - Lifetime ES2168334T3 (es) 1994-04-25 1995-04-13 Composicion para el tratamiento de la piel.

Country Status (7)

Country Link
US (1) US5451405A (es)
EP (1) EP0684040B1 (es)
JP (1) JPH07291851A (es)
CA (1) CA2147341C (es)
DE (1) DE69524138T2 (es)
ES (1) ES2168334T3 (es)
ZA (2) ZA953256B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07238010A (ja) * 1994-02-24 1995-09-12 Kanebo Ltd 皮膚化粧料
JPH07291846A (ja) * 1994-04-26 1995-11-07 Kanebo Ltd 皮膚化粧料
US5690944A (en) * 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
US5691380A (en) * 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
US20060089291A1 (en) * 2002-07-26 2006-04-27 Pz Cussons (International) Limited Cleaning composition
FR2740340B1 (fr) * 1995-10-30 1997-12-05 Oreal Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
DE19543695A1 (de) * 1995-11-23 1997-05-28 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von alpha-Hydroxyalkansäuren und Squalen
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19816039A1 (de) * 1998-04-09 1999-10-14 Eva Czybulski Entfernungsmittel für Augenschminke
AU3955599A (en) * 1998-06-04 1999-12-20 Kanebo Limited Alpha-hydroxy fatty acid derivatives and composition for external use containingthe same
FR2780886B1 (fr) * 1998-07-08 2001-06-29 Jean Noel Thorel Composition auto-hydratante pour la peau
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6808716B2 (en) 1999-01-08 2004-10-26 Ruey J. Yu N-acetylamino acids, related N-acetyl compounds and their topical use
GB9918025D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
WO2001082881A1 (fr) * 2000-04-28 2001-11-08 Ceramide Co., Ltd. Compositions de frisage et methode de frisage utilisant ces compositions
CA2415882A1 (en) * 2000-07-13 2002-01-24 Skinmedica, Inc. Composition for topically delivering vitamin c
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
DE10244117A1 (de) * 2002-09-12 2004-04-08 Coty B.V. Wasserbeständige Mascara-Zusammensetzung
US20040185018A1 (en) * 2003-02-03 2004-09-23 Patil Anjali Abhimanyu Nail enamelcompositions and methods
US20050019356A1 (en) * 2003-07-25 2005-01-27 The Procter & Gamble Company Regulation of mammalian keratinous tissue using N-acyl amino acid compositions
US20060286046A1 (en) * 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
WO2007039057A1 (en) * 2005-09-23 2007-04-12 Dsm Ip Assets B.V. Cosmetic compositions comprising hydroxyfatty acids
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
EP2045320B1 (de) * 2007-09-19 2012-04-25 Bubbles & Beyond Gmbh Reinigungsmittel zur Entfernung von Farbschichten von Oberflächen, Verfahren zur Herstellung des Mittels und Verfahren zur Reinigung
DE102008062237A1 (de) * 2008-12-16 2010-06-17 Henkel Ag & Co. Kgaa Reduktive Entfärbung keratinhaltiger Fasern
DE102009014380A1 (de) 2009-03-26 2010-10-07 Bubbles And Beyond Gmbh Verfahren und Zusammensetzung zum Reinigen von Gegenständen
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
EP3250196A4 (en) * 2015-01-27 2018-09-26 Florengale, LLC Healing topical composition

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE150694C (es) *
CA873359A (en) * 1971-06-15 A. Martin Tellis Zinc mercaptide n-acetylcysteine carboxylate salts
US3242052A (en) * 1963-08-13 1966-03-22 Mead Johnson & Co Hair treatment with nu-acylcysteines
US3591686A (en) * 1967-08-01 1971-07-06 Mead Johnson & Co Anti-inflammatory compositions and methods utilizing n-acylcysteines and the beta-alkyl and carboxyl derivatives thereof
US3647834A (en) * 1969-08-11 1972-03-07 Mead Johnson & Co Zinc mercaptide n-acetylcysteine carboxylate salts
US3749770A (en) * 1969-08-11 1973-07-31 Mead Johnson & Co Compositions containing zinc mercaptide n-acetylcysteine carboxylate salts
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
US4016287A (en) * 1972-07-17 1977-04-05 Boehringer Ingelheim Gmbh Dermatological compositions containing an acylamino-carboxylic acid or an alkyl ester thereof
FR2244541A1 (en) * 1973-08-01 1975-04-18 Fabre Sa Pierre Amino acid salts of quinine alkaloids - as phospho-lipase inhibitors and anti-acne agents
US4164570A (en) * 1973-09-24 1979-08-14 David Clough Stabilized aqueous catecholamine solutions
JPS52128241A (en) * 1976-04-19 1977-10-27 Kyowa Hakko Kogyo Co Ltd Reagents for permanent wave
US4093739A (en) * 1977-06-15 1978-06-06 Mead Johnson & Company Mercaptoacylamidobenzoyl glycine and mucolytic process
CH632668A5 (de) * 1977-12-09 1982-10-29 Hoffmann La Roche Kosmetisches mittel.
BR7904612A (pt) * 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
US4331648A (en) * 1979-12-05 1982-05-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
GB2180153A (en) * 1985-09-10 1987-03-25 Rory Ltd Compositions containing acetylcysteine
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
CA1321349C (en) * 1986-11-21 1993-08-17 Robert Zimmerman Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
US4868114A (en) * 1987-08-05 1989-09-19 Regents Of The University Of Minnesota Method for elevating glutathione levels
DE3727896A1 (de) * 1987-08-21 1989-03-02 Degussa Verfahren zur herstellung von salzen des n-acetylcysteins oder -homocysteins
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
FR2651129B1 (fr) * 1989-08-31 1991-12-13 Bfb Etud Rech Eperimentales Nouveaux derives de cysteine; compositions pharmaceutiques ou cosmetiques en contenant.
JPH03184922A (ja) * 1989-12-14 1991-08-12 Pola Chem Ind Inc 皮膚外用剤
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
DE69127020T2 (de) * 1990-05-18 1998-01-29 Iwase Cosfa Co Ltd Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
FR2666226B1 (fr) * 1990-08-30 1994-10-28 Jean Noel Thorel Composition protectrice de la peau.
US5118707A (en) * 1990-10-31 1992-06-02 The Procter & Gamble Company Compositions for regulating skin wrinkles comprising a benzofuran derivative
GB9109965D0 (en) * 1991-05-07 1991-07-03 Unilever Plc Cosmetic composition
TW222591B (es) * 1991-08-30 1994-04-21 Procter & Gamble
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
CA2122923C (en) * 1991-11-25 1999-01-19 Roy L. Blank Compositions for regulating skin wrinkles and/or skin atrophy
DE4242876C2 (de) * 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde

Also Published As

Publication number Publication date
EP0684040A2 (en) 1995-11-29
EP0684040A3 (en) 1995-12-13
JPH07291851A (ja) 1995-11-07
CA2147341C (en) 2005-08-23
CA2147341A1 (en) 1995-10-26
DE69524138T2 (de) 2002-06-06
DE69524138D1 (de) 2002-01-10
EP0684040B1 (en) 2001-11-28
ZA953256B (en) 1996-10-21
US5451405A (en) 1995-09-19
ZA952356B (en) 1996-10-21

Similar Documents

Publication Publication Date Title
ES2168334T3 (es) Composicion para el tratamiento de la piel.
AR023093A1 (es) Composiciones cosmeticas para la piel con contenido de dextrano y un acido carboxilico debil.
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
MY109928A (en) Fatty acid treatment
AR009097A1 (es) Una composicion para el acondicionamiento de la piel que contiene una amida y un retinoide y un metodo cosmetico, no terapeutico, para el acondicionamiento de la piel que comprende la aplicacion de dicha composicion
BR9803281A (pt) Composição contendo hidróxi-ácido e reinóide; e; processo cosmético para reduzir picada ou irritação induzida pela aplicação local de uma composição contendo um hidróxi-ácido ou um retinóide.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
ES2107762T3 (es) Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo.
ES2117646T3 (es) Alteracion de la velocidad y el caracter del crecimiento del pelo.
ES2022610B3 (es) Compuestos para potenciar la permeabilidad de la piel que utilizan esteres de sacarosa.
ATE120482T1 (de) Enzymatisches verfahren zur verminderung des gehaltes an phosphorhaltigen bestandteilen in pflanzl. u. tierischen olen.
ES2155473T3 (es) Composicion veterinaria que contiene un inhibidor de las bombas de protones.
DE3850109D1 (de) 13-trans-retinsäureester.
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
AR005234A1 (es) Un tratamiento para la piel estructuralmente deteriorada y composicion cosmetica utilizada en el mismo
ES2194679T3 (es) Composiciones cosmeticas que contienen creatina, carnitina y/o acido piruvico.
ES2088655T3 (es) Esteres de l-carnitina y alcanoil l-carnitinas con acido glicolico o sus esteres y composiciones farmaceuticas que las contienen para tratar dermatosis.
ES8704957A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
PT93946A (pt) Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem
ES2111355T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para el tratamiento de dermatosis.
ES2109412T3 (es) (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
ES2194157T3 (es) Composiciones para el cuidado de la piel que contienen un retinoide.
ES2045074T3 (es) Empleo de compuestos que contengan bisguanidos contra las huevas del oxiuro vermicular.
ES2139061T3 (es) Preparado para la piel y las mucosas, con contenido en acido nitrico.
ES2191211T3 (es) Uso de acido peracetico en piscicultura.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 684040

Country of ref document: ES